4
Changes in Ownership
Immunovant, Inc. Filed Acc 0001764013-25-000059
Chief Legal Officer acquired 50,787 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Van Tuyl Christopher Chief Legal Officer | 2025-04-01 | Grant or award | +50,787 | 160,743 | D | ||
| Derivatives | |||||||
| Van Tuyl Christopher Chief Legal Officer | 2025-04-01 | Grant or award · Stock Option (right to buy) | +71,531 | 71,531 | D | ||
Loading xslF345X05/wk-form4_1743713694.xml…